
Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting



Conditions: Leukemia, Myeloid, Acute
Interventions: Drug: DFP-10917; Drug: Venetoclax
Sponsors: Delta-Fly Pharma, Inc.
Not yet recruiting
Understanding the Study on Memantine for Tinnitus What is Tinnitus? Tinnitus is a condition where people hear sounds that aren’t actually there, like ringing or buzzing. It can be annoying…
KIADEKU Project Overview The KIADEKU project is focused on improving wound care for conditions like incontinence-associated dermatitis (IAD) and pressure ulcers (PU) by using an AI application. This project combines…
Study: Pigtail with Self-Retaining Bicanalicular Intubation and Mitomycin C for Lower Punctal Stenosis Background The study used a pigtail to create an opening at the lower punctal site in grade…
Understanding the Trial Results This study looked at a treatment for early-stage knee osteoarthritis (OA), a common condition that causes pain and disability. The researchers tested a single dose of…
Study Overview This study looked at how a medication called brexpiprazole can help people with both schizophrenia and substance use problems. It lasted for 12 weeks and involved two groups…
Understanding the Study Results This study looked at different ways to treat melasma, a common skin condition. Melasma can be hard to treat because existing treatments often have side effects…
Background Mirvetuximab soravtansine (MIRV) is a new treatment for women with platinum-resistant ovarian cancer. It targets a specific protein (folate receptor α) on cancer cells. This treatment has been approved…